NCT07169578: A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- State
- Under way
- Phase
- Phase 3
- People
- 1,101 taking part
- Started
- 17 Sep 2025
- Primary completion
- 16 Feb 2028
- Arms
- Trontinemab
- Results
- None posted
- 12 Sep 2025: Trial registered
- 17 Sep 2025: Trial started